83789 CPT® code: payer coverage and prior authorization83789 appears in 8 coverage policies from Aetna, Blue Cross & Blue Shield of Mississippi, Blue Cross NC, Cigna.
| Payer | Policy | Role in policy | Reviewed | Document |
|---|---|---|---|---|
| Aetna | Inflammatory Disease: Biomarker and Thiopurine Pharmacogenomic Testing (0249) | not covered | Apr 27, 2026 | payer document |
| Aetna | Pharmacogenetic and Pharmacodynamic Testing (0715) | covered if criteria are met | Oct 8, 2026 | payer document |
| Aetna | Transthyretin-Mediated (ATTR) Amyloidosis (0939) | listed, no stance | Aug 10, 2026 | payer document |
| Aetna | Tumor Markers (0352) | covered if criteria are met | Aug 25, 2026 | payer document |
| Blue Cross & Blue Shield of Mississippi | Organic Acid Testing (L.2.04.413) | not covered | payer document | |
| Blue Cross NC | Professional Pathology Billing Requirements AHS – R2169 | listed, no stance (range 83001-83993) | Mar 1, 2024 | payer document |
| Blue Cross NC | Testing for Alpha-1 Antitrypsin Deficiency AHS - M2068 | listed, no stance | Oct 1, 2025 | payer document |
| Cigna | Laboratory Testing Services (0604) | not covered | May 15, 2026 | payer document |
From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.